EFM
KDNY

E Fund Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

E Fund Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,196
Closed -$430K – 327
2023
Q2 		$430K Buy
11,196
+907
+9% +$34.8K 0.03% 149
2023
Q1 		$238K Buy
10,289
+1,172
+13% +$27.1K 0.02% 266
2022
Q4 		$239K Buy
+9,117
New +$239K 0.02% 270